Oscar Health (OSCR) to Release Quarterly Earnings on Wednesday

Oscar Health (NYSE:OSCR - Get Free Report) is expected to post its Q1 2025 quarterly earnings results before the market opens on Wednesday, May 7th. Analysts expect Oscar Health to post earnings of $0.83 per share and revenue of $2.87 billion for the quarter. Oscar Health has set its FY 2025 guidance at EPS.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, beating analysts' consensus estimates of $0.83 by $0.09. The company had revenue of $3 billion for the quarter, compared to analyst estimates of $2.87 billion. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The company's quarterly revenue was up 42.2% compared to the same quarter last year. During the same period last year, the company earned $0.62 earnings per share. On average, analysts expect Oscar Health to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Oscar Health Price Performance

OSCR traded up $3.96 on Wednesday, reaching $17.03. The company had a trading volume of 28,734,900 shares, compared to its average volume of 4,014,900. Oscar Health has a one year low of $11.20 and a one year high of $23.79. The company has a market capitalization of $4.27 billion, a P/E ratio of -850.87 and a beta of 1.75. The company has a fifty day moving average of $13.27 and a 200-day moving average of $14.62. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26.

Institutional Investors Weigh In On Oscar Health

An institutional investor recently raised its position in Oscar Health stock. Thrive Capital Management LLC raised its position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 33.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 6,343,617 shares of the company's stock after buying an additional 1,588,395 shares during the quarter. Oscar Health accounts for 38.3% of Thrive Capital Management LLC's portfolio, making the stock its 2nd largest position. Thrive Capital Management LLC owned about 2.53% of Oscar Health worth $85,258,000 as of its most recent filing with the Securities and Exchange Commission. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, Wells Fargo & Company cut Oscar Health from an "overweight" rating to an "equal weight" rating and dropped their target price for the stock from $20.00 to $16.00 in a report on Thursday, March 13th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating, two have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $20.21.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.